212 related articles for article (PubMed ID: 32114396)
1. Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
Zhao XC; Wang GZ; Wen ZS; Zhou YC; Hu Q; Zhang B; Qu LW; Gao SH; Liu J; Ma L; Zhang YF; Zhang C; Yu H; Zhang DL; Wang M; Wang CL; Huang YC; Liu ZH; Zhao Y; Chen L; Zhou GB
EBioMedicine; 2020 Mar; 53():102689. PubMed ID: 32114396
[TBL] [Abstract][Full Text] [Related]
2. Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer.
Zhang Y; Zhao X; Zhou Y; Wang M; Zhou G
Front Med; 2020 Jun; 14(3):318-326. PubMed ID: 31571161
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
[TBL] [Abstract][Full Text] [Related]
4. Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
Zhang S; Sun Y
EBioMedicine; 2020 Apr; 54():102718. PubMed ID: 32268269
[No Abstract] [Full Text] [Related]
5. Identification of a potential tumor suppressor gene,
Zhao X; Yongchun Z; Qian H; Sanhui G; Jie L; Hong Y; Yanfei Z; Guizhen W; Yunchao H; Guangbiao Z
Cancer Biol Med; 2020 Feb; 17(1):76-87. PubMed ID: 32296577
[No Abstract] [Full Text] [Related]
6. Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer.
Yang YC; Pan KF; Lee WJ; Chang JH; Tan P; Gu CC; Chang WM; Yang SF; Hsiao M; Hua KT; Chien MH
Cancer Res; 2020 Aug; 80(16):3292-3304. PubMed ID: 32561533
[TBL] [Abstract][Full Text] [Related]
7. UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.
Pallante P; Malapelle U; Berlingieri MT; Bellevicine C; Sepe R; Federico A; Rocco D; Galgani M; Chiariotti L; Sanchez-Cespedes M; Fusco A; Troncone G
Eur J Cancer; 2013 Mar; 49(5):1117-26. PubMed ID: 23102841
[TBL] [Abstract][Full Text] [Related]
8. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations.
Yang K; Chen Y; Zhou J; Ma L; Shan Y; Cheng X; Wang Y; Zhang Z; Ji X; Chen L; Dai H; Zhu B; Li C; Tao Z; Hu X; Yin W
Br J Pharmacol; 2019 Dec; 176(24):4609-4624. PubMed ID: 31322286
[TBL] [Abstract][Full Text] [Related]
11. Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells.
Yao S; Shi F; Wang Y; Sun X; Sun W; Zhang Y; Liu X; Liu X; Su L
Cell Signal; 2019 Sep; 61():10-19. PubMed ID: 31075398
[TBL] [Abstract][Full Text] [Related]
12. Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
[TBL] [Abstract][Full Text] [Related]
13. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
[No Abstract] [Full Text] [Related]
14. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
[TBL] [Abstract][Full Text] [Related]
15. Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.
Ray D; Ahsan A; Helman A; Chen G; Hegde A; Gurjar SR; Zhao L; Kiyokawa H; Beer DG; Lawrence TS; Nyati MK
Neoplasia; 2011 Jul; 13(7):570-8. PubMed ID: 21750651
[TBL] [Abstract][Full Text] [Related]
16. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
17. Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer.
Wei TT; Lin YC; Lin PH; Shih JY; Chou CW; Huang WJ; Yang YC; Hsiao PW; Chen CC
Oncotarget; 2015 May; 6(14):12481-92. PubMed ID: 25980579
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
[TBL] [Abstract][Full Text] [Related]
19. Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer.
Mao J; Ma L; Shen Y; Zhu K; Zhang R; Xi W; Ruan Z; Luo C; Chen Z; Xi X; Chen S
Cell Death Dis; 2018 Sep; 9(10):963. PubMed ID: 30237564
[TBL] [Abstract][Full Text] [Related]
20. CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Chavdoula E; Habiel DM; Roupakia E; Markopoulos GS; Vasilaki E; Kokkalis A; Polyzos AP; Boleti H; Thanos D; Klinakis A; Kolettas E; Marcu KB
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
